New Finger-Prick Blood Test Shows Promise for Early dementia Detection, With Focus on Diverse Populations
A new finger-prick blood test is being investigated for its potential to screen for early signs of dementia, offering a less invasive and substantially more affordable alternative to current diagnostic methods like expensive brain scans and lumbar punctures.The study, known as Bio-Hermes-002, aims to validate this approach in a large, internationally diverse population.
currently, diagnosing dementia often relies on identifying symptoms after significant brain damage has occurred. This new test focuses on identifying biomarkers – measurable indicators of a biological state or condition – that could signal the very early stages of neurodegenerative diseases like Alzheimer’s. Early detection is crucial as emerging treatments are expected to be most effective when administered in the initial phases of the disease.
The Bio-Hermes-002 study is particularly focused on inclusivity, aiming for at least 25% of its volunteers to come from under-represented ethnic groups. This is a vital step towards addressing a significant health equity gap. Research indicates that Black and Hispanic individuals are disproportionately affected by Alzheimer’s disease,being twice as likely to develop it compared to white individuals. However, thes communities are drastically underrepresented in clinical trials – participation rates often fall between 2% and 20%.
This lack of diversity in research poses a serious challenge to the future of personalized medicine. Effective treatments and preventative strategies need to be developed based on a comprehensive understanding of disease risk across all populations. The data gathered from the Bio-Hermes-002 project is intended to help ensure that future advancements benefit all patients equitably.
The trial is expected to be completed in 2028. While further validation is needed before the test can be implemented within the National Health Service (NHS), the development represents a significant step forward in the fight against dementia and its impact on individuals and healthcare systems.
Sources:
* Med-Tech Insights: https://www.med-techinsights.com/news/bio-hermes-002-study-finger-prick-blood-test-dementia/
* National Institute on Aging (Alzheimer’s and related dementias): https://www.nia.nih.gov/health/alzheimers-and-dementia
* Alzheimer’s Association: https://www.alz.org/
Related reading